Rampart Bioscience
Latest round
- Seed
Last raised
- Oct 2023
Total raised
- $101M
Investors
- 4
About Rampart Bioscience
, operates as a biotech company that develops gene medicines and offers proprietary development and delivery platforms. As of 2023, the company was founded by its Chief Innovation and Technical Officer, Jeffrey Bartlett, CEO, Louis Breton. The company offers various gene therapy solutions that include gene delivery, protein sciences, and clinical translation solutions. The company uses a non-viral DNA delivery system used for treating an inherited metabolic disorder and high-need applications in genetic disease.
Who invested in Rampart Bioscience
4 investors across 2 rounds
See all investors in Rampart Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rampart Bioscience
Who invested in Rampart Bioscience?
Rampart Bioscience has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rampart Bioscience raised?
Rampart Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rampart Bioscience last raise money?
Rampart Bioscience's most recent round on record is a Seed, in Oct 2023.
What does Rampart Bioscience do?
, operates as a biotech company that develops gene medicines and offers proprietary development and delivery platforms.
Where is Rampart Bioscience headquartered?
Rampart Bioscience is headquartered in US.
Which VCs invest in companies like Rampart Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rampart Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Rampart Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.